CanadaBis Capital Inc. (CNADF)
OTCMKTS · Delayed Price · Currency is USD
0.0625
-0.0005 (-0.79%)
At close: Apr 10, 2025
CanadaBis Capital Revenue
CanadaBis Capital had revenue of 3.24M CAD in the quarter ending April 30, 2025, a decrease of -18.46%. This brings the company's revenue in the last twelve months to 17.16M, down -8.84% year-over-year. In the fiscal year ending July 31, 2024, CanadaBis Capital had annual revenue of 17.95M, down -19.20%.
Revenue (ttm)
17.16M CAD
Revenue Growth
-8.84%
P/S Ratio
0.32
Revenue / Employee
n/a
Employees
n/a
Market Cap
4.00M USD
Revenue Chart
* This company reports financials in CAD.
Revenue History
Fiscal Year End | Revenue | Change | Growth |
---|---|---|---|
Jul 31, 2024 | 17.95M | -4.27M | -19.20% |
Jul 31, 2023 | 22.22M | 10.55M | 90.44% |
Jul 31, 2022 | 11.67M | 4.80M | 69.95% |
Jul 31, 2021 | 6.87M | 2.44M | 55.04% |
Jul 31, 2020 | 4.43M | - | - |
Jul 31, 2019 | Upgrade Pro | Upgrade Pro | Upgrade Pro |
Jul 31, 2018 | Upgrade Pro | Upgrade Pro | Upgrade Pro |
Jul 31, 2017 | Upgrade Pro | Upgrade Pro | Upgrade Pro |
Revenue Definition
Revenue, also called sales, is the amount of money a company receives from its business activities, such as sales of products or services. Revenue does not take any expenses into account and is therefore different from profits.
Full DefinitionRelated Stocks
Company Name | Revenue |
---|---|
Veradigm | 588.02M |
Tian'an Technology Group | 2.12M |
Elite Pharmaceuticals | 105.45M |
Glass House Brands | 221.55M |
Northwest Biotherapeutics | 1.09M |
American Oncology Network | 1.76B |
Silence Therapeutics | 27.17M |
AMJ Global Technology | 39.00 |